CN Patent

CN114096268A — 用于增加患有胆汁淤积性肝病的儿科受试者的生长的方法

Assigned to Mirum Pharmaceuticals Inc · Expires 2022-02-25 · 4y expired

What this patent protects

本文提供了用于增加患有胆汁淤积性肝病的儿科受试者的生长的方法。所述方法包括向所述受试者施用有效量的ASBTI。

USPTO Abstract

本文提供了用于增加患有胆汁淤积性肝病的儿科受试者的生长的方法。所述方法包括向所述受试者施用有效量的ASBTI。

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CN114096268A
Jurisdiction: CN
Classification: —
Expires: 2022-02-25
Drug substance claim: No
Drug product claim: No
Assignee: Mirum Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.